How Blood-Based Biofluid Testing Is Revolutionizing Cancer Diagnostics

In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.

Among the topics they dig into are:

The benefits of blood-based biofluid testing over traditional, more invasive methods.
How biofluid testing saves money and improves access for patients.
How labs can add blood-based biofluid testing onto their diagnostic menus.
The importance of proper sample collection.
The renaissance in the use of blood-based biomarkers in diagnostic testing.

Poddgruvan

How Blood-Based Biofluid Testing Is Revolutionizing Cancer Diagnostics

Advancements in HLA Matching and Antibody Detection

What Do the New ASCCP Guidelines Mean for Clinical Labs?

Alpha-Synuclein: Adding Precision to Neurodegenerative Testing

C Diff: How Awareness Improves Diagnostics and Treatments

HPV Self-Sampling Is Being Put into Practice in Texas

Will HPV Self-Collection Help Prevent Cervical Cancer?

It’s Simple: Point-of-Care Testing Improves Access

How You Can Harness AI in Your Laboratory

From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

Kids and Science: Is this THE Recipe for Solving the Laboratorian Shortage?